Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations | Managed Healthcare Executive
Nonfactor Therapies for Hemophilia Hemophilia is a congenital, X-linked bleeding disorder caused by deficiencies in coagulation factor VIII (FVIII) or factor IX (FIX) due to mutations in t…